---
title: "Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304014788.md"
description: "Aspen Neuroscience's amended bylaws took effect on November 2, 2026, coinciding with its IPO closing. The company issued 9,375,000 common shares at $15 each, generating approximately $140.6 million in gross proceeds before deducting underwriting discounts and expenses."
datetime: "2026-11-02T21:55:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304014788.md)
  - [en](https://longbridge.com/en/news/304014788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304014788.md)
generator: "portal-rs"
---

# Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing

-   Aspen Neuroscience’s amended and restated bylaws became effective Nov. 2, 2026, in connection with its IPO closing. \* The IPO comprised 9,375,000 common shares priced at $15 per share. \* Gross proceeds totaled approximately $140.6 million before underwriting discounts, commissions and offering expenses. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-443805), on November 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASPE.US](https://longbridge.com/en/quote/ASPE.US.md)
- [1F3.SG](https://longbridge.com/en/quote/1F3.SG.md)

## Related News & Research

- [ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience](https://longbridge.com/en/news/304929595.md)
- [OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares](https://longbridge.com/en/news/304354913.md)
- [ARCH Venture Fund XIV Reports Acquisition of $18 Million in Aspen Neuroscience Common Shares](https://longbridge.com/en/news/304042044.md)
- [OrbiMed Advisors Discloses Investment at Aspen Neuroscience, Inc. with 12.3% Stake](https://longbridge.com/en/news/304700413.md)
- [BUZZ-Aspen Neuroscience set to open higher in debut after $141 million US IPO](https://longbridge.com/en/news/303774451.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**